Rockefeller Capital Management
IGC icon

Rockefeller Capital Management’s IGC Pharma IGC Stock Holding History

Rockefeller Capital Management’s Portfolio IGC Stock Details IGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$272 Buy
+1,000
New +$296 ﹤0.01% 4641

Other funds holding IGC

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
LC
Lawood & Co Williamsport, Pennsylvania $148M AUM

Rockefeller Capital Management's IGC Position: Q2 2026 in Review

Rockefeller Capital Management opened a new position in IGC Pharma (IGC) in Q2 2026: 1,000 shares worth $272. The stake represents ﹤0.01% of the portfolio and ranks #4641 among its holdings.

36 funds tracked by Wall St. Rank hold IGC as of Q2 2026.

  • Rockefeller Capital Management held 1,000 shares of IGC Pharma worth $272 as of Q2 2026.
  • IGC Pharma was a new Rockefeller Capital Management position in Q2 2026.
  • IGC Pharma made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #4641 holding.
  • 36 funds tracked by Wall St. Rank held IGC Pharma as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.